Proton MR Spectroscopic Imaging in Pelizaeus-Merzbacher Disease

References

1. ↵
   Hodes ME, Pratt VM, Dlouhy SR. Genetics of Pelizaeus-Merzbacher disease. Dev Neurosci 1993;15:383–394

   CrossRefPubMedWeb of Science
2. ↵
   Woodward K, Malcolm S. Proteolipid protein gene: Pelizaeus-Merzbacher disease in humans and neurodegeneration in mice. Trends Genet 1999;15:125–128

   CrossRefPubMedWeb of Science
3. ↵
   Anderson TJ, Schneider A, Barrie JA, et al. Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J Comp Neurol 1998;394:506–519

   CrossRefPubMedWeb of Science
4. ↵
   Garbern J, Cambi F, Shy M, Kamholz J. The molecular pathogenesis of Pelizaeus-Merzbacher disease. Arch Neurol 1999;56:1210–1214

   CrossRefPubMedWeb of Science
5. ↵
   Garbern JY, Yool DA, Moore GJ, et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 2002;125:551–561

   Abstract/FREE Full Text
6. ↵
   Barkovich AJ. Concepts of myelin and myelination in neuroradiology. AJNR Am J Neuroradiol 2000;21:1099–1109

   FREE Full Text
7. ↵
   Barker PB. N-Acetyl aspartate: a neuronal marker? Ann Neurol 2001;49:423–424

   CrossRefPubMedWeb of Science
8. ↵
   Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981–989

   Abstract
9. ↵
   Grodd W, Krageloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991;181:173–181

   CrossRefPubMedWeb of Science
10. ↵
    Takanashi J, Sugita K, Osaka H, Ishii M, Niimi H. Proton MR spectroscopy in Pelizaeus-Merzbacher disease. AJNR Am J Neuroradiol 1997;18:533–535

    Abstract
11. Lam WW, Wang ZJ, Zhao H, et al. 1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis. Neuroradiology 1998;40:315–323

    CrossRefPubMedWeb of Science
12. ↵
    Nezu A, Kimura S, Takeshita S, Osaka H, Kimura K, Inoue K. An MRI and MRS study of Pelizaeus-Merzbacher disease. Pediatr Neurol 1998;18:334–337

    CrossRefPubMedWeb of Science
13. ↵
    Spalice A, Popolizio T, Parisi P, Scarabino T, Iannetti P. Proton MR spectroscopy in connatal Pelizaeus-Merzbacher disease. Pediatr Radiol 2000;30:171–175

    CrossRefPubMed
14. ↵
    Bonavita S, Schiffmann R, Moore DF, et al. Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations. Neurology 2001;56:785–788

    Abstract/FREE Full Text
15. Takanashi J, Inoue K, Tomita M, et al. Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication. Neurology 2002;58:237–241

    Abstract/FREE Full Text
16. ↵
    Hobson GM, Huang Z, Sperle K, Stabley DL, Marks HG, Cambi F. A PLP splicing abnormality is associated with an unusual presentation of PMD. Ann Neurol 2002;52:477–488

    CrossRefPubMedWeb of Science
17. ↵
    Garbern J, Shy M, Krajewski K, Kamholz J, Hobson G, Cambi F. Evidence for neuroaxonal injury in patients with proteolipid gene mutations. Neurology 2001;57:1938–1939

    FREE Full Text
18. ↵
    Hodes ME, Zimmerman AW, Aydanian A, et al. Different mutations in the same codon of the proteolipid protein gene, PLP, may help in correlating genotype with phenotype in Pelizaeus-Merzbacher disease/X-linked spastic paraplegia (PMD/SPG2). Am J Med Genet 1999;82:132–139

    CrossRefPubMedWeb of Science
19. ↵
    Duyn JH, Gillen J, Sobering G, van Zijl PCM, Moonen CTW. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277–282

    CrossRefPubMedWeb of Science
20. ↵
    Soher BJ, van Zijl PCM, Duyn JH, Barker PB. Quantitative proton spectroscopic imaging of the human brain. Magn Reson Med. 1996;35:356–363

    PubMedWeb of Science
21. ↵
    Pratt VM, Naidu S, Dlouhy SR, Marks HG, Hodes ME. A novel mutation in exon 3 of the proteolipid protein gene in Pelizaeus-Merzbacher disease. Neurology 1995;45:394–395

    FREE Full Text
22. ↵
    Naidu S, Dlouhy SR, Geraghty MT, Hodes ME. A male child with the rumpshaker mutation, X-linked spastic paraplegia/Pelizaeus-Merzbacher disease and lysinuria. J Inherit Metab Dis 1997;20:811–816

    CrossRefPubMedWeb of Science
23. ↵
    Horská A, Kaufmann WE, Brant LJ, Naidu S, Harris JC, Barker PB. In vivo quantitative proton MRSI study Of brain development from childhood to adolescence. J Magn Reson Imag. 2002;15:137–143

    CrossRefPubMedWeb of Science
24. ↵
    Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med. 1993;30:424–437

    CrossRefPubMedWeb of Science
25. ↵
    Mastronardi FG, Ackerley CA, Arsenault L, Roots BI, Moscarello MA. Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res 1993;36:315–324

    CrossRefPubMedWeb of Science
26. ↵
    Bradl M, Bauer J, Inomata T, et al. Transgenic Lewis rats overexpressing the proteolipid protein gene: myelin degeneration and its effect on T cell-mediated experimental autoimmune encephalomyelitis. Acta Neuropathol (Berl) 1999;97:595–606

    CrossRefPubMedWeb of Science
27. ↵
    Best TT, Skoff RP, Bartlett WP. Astroglial plasticity in hemizygous and heterozygous jimpy mice. Int J Dev Neurosci 1988;6:39—57

    PubMed
28. ↵
    Kruse B, Barker PB, van Zijl PCM, Duyn JH, Moonen CTW, Moser HW. Multislice proton MR spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol 1994;36:595–608

    CrossRefPubMedWeb of Science
29. ↵
    Griffiths I, Klugmann M, Anderson T, et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998;280:1610–1613

    Abstract/FREE Full Text
30. ↵
    Barker PB, Bryan RN, Kumar AJ, Naidu S. Proton NMR spectroscopy of Canavan’s disease. Neuropediatrics 1992;23:263–267

    CrossRefPubMedWeb of Science
31. ↵
    Pouwels PJW, Brockmann K, Kruse B, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999;46:474–485

    CrossRefPubMedWeb of Science